Distinguished Professor and Executive Chairman of Surgery, UCLA
General Surgery
Dr. Ronald W. Busuttil, MD
|
|
Give Review
Ronald Busuttil is an expert in the field of General Surgery. He studied medicine at Tulane University School of Medicine. He received 6 awards: "America's Top Doctors", "Top Doctors:LA Area", "America's Top Doctors for Cancer", "Top Doctors:Southern California", "Super Doctor" and "Fellow (FACS)". Ronald Busuttil is a published doctor. He has 102 papers published. The most current publication "Intraoperative Laparoscopic Near-Infrared Fluorescence Cholangiography to Facilitate Anatomical Identification: When to Give Indocyanine Green and How Much." Ronald Busuttil accepts Medicare.
Publications
- Sofosbuvir and simeprevir is effective for recurrent hepatitis C in liver transplant recipients.
- Liver transplantation: Evading antigens-ABO-incompatible liver transplantation.
- Damage Control as a Strategy to Manage Postreperfusion Hemodynamic Instability and Coagulopathy in Liver Transplant.
- Hyperglycemia and Liver Ischemia Reperfusion Injury: A Role for the Advanced Glycation Endproduct and Its Receptor Pathway.
- A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients.
- Negative CD4 + TIM-3 Signaling Confers Resistance Against Cold Preservation Damage in Mouse Liver Transplantation.
- Survival benefit of solid-organ transplant in the United States.
- Cardiac tamponade following liver transplantation after intrapericardial control of the suprahepatic vena cava.
- Rapamycin protection of livers from ischemia and reperfusion injury is dependent on both autophagy induction and mammalian target of rapamycin complex 2-Akt activation.
- T-cell immunoglobulin and mucin domain 4 (TIM-4) signaling in innate immune-mediated liver ischemia-reperfusion injury.
- Randomized, double-blind trial of anidulafungin versus fluconazole for prophylaxis of invasive fungal infections in high-risk liver transplant recipients.
- Autologous Islet Transplantation With Remote Islet Isolation After Pancreas Resection for Chronic Pancreatitis.
- Restoration of portal flow with a pericholedochal varix in adult living donor liver transplantation for patients with total portosplenomesenteric Thrombosis.
- Balloon-Occluded Retrograde TransVenous Obliteration (BRTO) for Treatment of Gastric Varices: Review and Meta-Analysis.
- Recipient T cell TIM-3 and hepatocyte galectin-9 signalling protects mouse liver transplants against ischemia-reperfusion injury.
- A 20-year experience with liver transplantation for polycystic liver Disease: does previous palliative surgical intervention affect outcomes?
- ATF6 Mediates a Pro-Inflammatory Synergy Between ER Stress and TLR Activation in the Pathogenesis of Liver Ischemia-Reperfusion Injury.
- Liver transplantation in recipients receiving renal replacement therapy: outcomes analysis and the role of intraoperative hemodialysis.
- Myeloid PTEN Deficiency Protects Livers from Ischemia Reperfusion Injury by Facilitating M2 Macrophage Differentiation.
- Adoptive Transfer of HO-1 Modified Macrophages Rescues Nrf2 Anti-Inflammatory Phenotype in Liver Ischemia/Reperfusion Injury.
- Perioperative Complications in Liver Transplantation Using Grafts from Donation after Cardiac Death: A Propensity-matched Study.
- Boceprevir in liver transplant recipients.
- MMP-9 deficiency shelters endothelial PECAM-1 expression and enhances regeneration of steatotic livers after ischemia and reperfusion injury.
- KEAP1-NRF2 complex in ischemia-induced hepatocellular damage of mouse liver transplants.
- Liver Transplantation in Children Using Organ Donation After Circulatory Death: A Case-Control Outcomes Analysis of a 20-Year Experience in a Single Center.
- Liver Transplantation in Highest Acuity Recipients: Identifying Factors to Avoid Futility.
- Multicenter review of liver transplant for hepatitis B-related liver Disease: disparities in gender and ethnicity.
- Vasoactive intestinal peptide attenuates liver ischemia/reperfusion injury in mice via the cyclic adenosine monophosphate-protein kinase a pathway.
- Liver transplantation: past, present and future.
- Molecular subtype and response to dasatinib, an Src/Abl small molecule kinase inhibitor, in hepatocellular carcinoma cell lines in vitro.
- Liver transplantation for lethal genetic Syndromes: a novel model of personalized genomic medicine.
- Low rates of short- and long-term graft loss after kidney-pancreas transplant from a single center.
- Blood Transfusion Requirement During Liver Transplantation is an Important Risk Factor for Mortality.
- β-catenin regulates innate and adaptive immunity in mouse liver ischemia-reperfusion injury.
- Complete tumor encapsulation on magnetic resonance imaging: A potentially useful imaging biomarker for better survival in solitary large hepatocellular carcinoma.
- Assessment of hepatic steatosis by transplant surgeon and expert pathologist a prospective, double-blind evaluation of 201 donor livers.
- Incidence, Timing, and Significance of Early Hypogammaglobulinemia After Intestinal Transplantation.
- The ASC/Caspase-1/IL-1? signaling triggers inflammatory responses by promoting HMGB1 induction in liver ischemia-reperfusion injury.
- PTEN-mediated Akt/?-catenin/Foxo1 signaling regulates innate immune responses in mouse liver ischemia/reperfusion injury.
- Accuracy of Stress Myocardial Perfusion Imaging to Diagnose Coronary Artery Disease in End Stage Liver Disease Patients.
- Ischaemia-reperfusion injury in liver transplantation-from bench to bedside.
- Targeting TIM-1 on CD4 T cells depresses macrophage activation and overcomes ischemia-reperfusion injury in mouse orthotopic liver transplantation.
- A Single-institution Retrospective Cases Series of Childhood Undifferentiated Embryonal Liver Sarcoma (UELS): Success of Combined Therapy and the Use of Orthotopic Liv...
- Liver Transplantation Outcome in Patients With Angiographically Proven Coronary Artery Disease: A Multi-Institutional Study.
- Treatment with antithymocyte globulin ameliorates intestinal ischemia and reperfusion injury in mice.
- Twenty-four years after liver transplantation, the recipient becomes a body donor.
- Endoplasmic Reticulum Stress Modulates Liver Inflammatory Immune Response in the Pathogenesis of Liver Ischemia and Reperfusion Injury.
- Neuropeptide PACAP in mouse liver ischemia and reperfusion injury: immunomodulation via cAMP-PKA pathway.
- Interleukin-22: Implications for Liver Ischemia-Reperfusion Injury.
- Transarterial chemoembolization plus or minus intraVenous bevacizumab in the treatment of hepatocellular cancer: A pilot study.
- Improvement in short-term pancreas transplant outcome by targeted antimicrobial therapy and refined donor selection.
- Tenascin-c: A novel mediator of hepatic ischemia and reperfusion injury.
- Risk of nephrogenic systemic fibrosis in liver transplantation patients.
- Liver transplantation using organ donation after cardiac death: a clinical predictive index for graft failure-free survival.
- Long-Term Nutrition and Predictors of Growth and Weight Gain Following Pediatric Intestinal Transplantation.
- Predictive Index for Long-Term Survival After Retransplantation of the Liver in Adult Recipients: Analysis of a 26-Year Experience in a Single Center.
- HO-1 - Stat3 axis in mouse liver ischemia/reperfusion injury: regulation of TLR4 innate responses through PI3K/PTEN signaling.
- Where are we today in split liver transplantation?.
- Comparative analysis of resection and liver transplantation for intrahepatic and hilar cholangiocarcinoma: a 24-year experience in a single center.
- Alloreactive CD8 T-cell primed/memory responses and accelerated graft rejection in B-cell-deficient sensitized mice.
- Type I Interferon Pathway Mediates Renal Ischemia/Reperfusion Injury.
- The inhibition of glycogen synthase kinase 3 beta ameliorates liver ischemia reperfusion injury via an IL-10-mediated immune regulatory mechanism.
- Development of a Disease-specific questionnaire to measure health-related quality of life in liver transplant recipients.
- Differences in health-related quality of life scores after orthotopic liver transplantation with respect to selected socioeconomic factors.
- Interleukin-13 protects mouse intestine from ischemia and reperfusion injury through regulation of innate and adaptive immunity.
- Predictive index for tumor recurrence after liver transplantation for locally advanced intrahepatic and hilar cholangiocarcinoma.
- Feasibility and safety of percutaneous coronary intervention in patients with end-stage liver Disease referred for liver transplantation.
- Identification of a therapeutic strategy targeting amplified FGF19 in liver cancer by Oncogenomic screening.
- Postliver transplant Acute renal injury and failure by the RIFLE criteria in patients with normal pretransplant serum creatinine concentrations: a matched study.
- Native macrophages genetically modified to express heme oxygenase 1 protect rat liver transplants from ischemia/reperfusion injury.
- CT and MRI improve detection of hepatocellular carcinoma, compared with ultrasound alone, in patients with cirrhosis.
- Pretransplant predictors of survival after intestinal transplantation: analysis of a single-center experience of more than 100 transplants.
- Incidental intracardiac thromboemboli during liver transplantation: incidence, risk factors, and management.
- T-cell immunoglobulin mucin-3 determines severity of liver ischemia/reperfusion injury in mice in a TLR4-dependent manner.
- Programmed death-1/B7-H1 negative costimulation protects mouse liver against ischemia and reperfusion injury.
- Long-term patient outcome and quality of life after liver transplantation: analysis of 20-year survivors.
- The protective function of neutrophil elastase inhibitor in liver ischemia/reperfusion injury.
- Adoptive transfer of ex vivo HO-1 modified bone marrow-derived macrophages prevents liver ischemia and reperfusion injury.
- Blockade of Janus kinase-2 signaling ameliorates mouse liver damage due to ischemia and reperfusion.
- The emerging role of T cell immunoglobulin mucin-1 in the mechanism of liver ischemia and reperfusion injury in the mouse.
- Predictors of survival following liver transplantation in infants: a single-center analysis of more than 200 cases.
- Endoscopic treatment of postorthotopic liver transplantation anastomotic biliary strictures with maximal stent therapy (with video).
- Survival in Asian Americans after treatments for hepatocellular carcinoma: a seven-year experience at UCLA.
- Improving outcomes after intestinal transplantation at the University of California, Los Angeles.
- Triple-drug transcatheter Arterial chemoembolization in unresectable hepatocellular carcinoma: assessment of survival in 124 consecutive patients.
- Recurrence of hepatocellular carcinoma and hepatitis B reinfection in hepatitis B surface antigen-positive patients after liver transplantation.
- CD4 T cells promote tissue inflammation via CD40 signaling without de novo activation in a murine model of liver ischemia/reperfusion injury.
- Groin herniorrhaphy in patients with cirrhosis and after liver transplantation.
- Small interfering RNA targeting heme oxygenase-1 (HO-1) reinforces liver apoptosis induced by ischemia-reperfusion injury in mice: HO-1 is necessary for cytoprotection.
- Surgical privileging and credentialing: a report of a discussion and study group of the American Surgical Association.
- Fulminant hepatic failure in children: superior and durable outcomes with liver transplantation over 25 years at a single center.
- The inhibition of neutrophil elastase ameliorates mouse liver damage due to ischemia and reperfusion.
- Endoscopic treatment with multiple stents for post-liver-transplantation nonanastomotic biliary strictures.
- Inducible nitric oxide synthase deficiency impairs matrix metalloproteinase-9 activity and disrupts leukocyte migration in hepatic ischemia/reperfusion injury.
- Vascular complications of orthotopic liver transplantation: experience in more than 4,200 patients.
- Longterm outcomes for whole and segmental liver grafts in adult and pediatric liver transplant recipients: a 10-year comparative analysis of 2,988 cases.
- Acetaminophen hepatotoxicity and Acute liver failure.
- Evolving surgical approaches in liver transplantation.
- Intragraft selection of the T cell receptor repertoire by class I MHC sequences in tolerant recipients.
- Tezosentan, a novel endothelin receptor antagonist, markedly reduces rat hepatic ischemia and reperfusion injury in three different models.
- Intraoperative Laparoscopic Near-Infrared Fluorescence Cholangiography to Facilitate Anatomical Identification: When to Give Indocyanine Green and How Much.
Schools
Tulane Univ Sch Of Med
University Of California Los Angeles
Procedures Preformed
- Dressing and-or Debridement of Wound, Infection, or Burn (incl. Negative Pressure Wound Therapy)
- Embolectomy, Thrombectomy, or Vessel Exploration
- Laparotomy
- Non-Coronary Angioplasty, Atherectomy, and Stenting
- View All
Conditions Treated
- Acute Deep Vein Thrombosis (DVT)
- Acute Venous Embolism Thrombosis
- Atherosclerosis of Aorta
- Carotid Artery Disease
- View All
Doctors Specialties
- General Surgery
- Vascular Surgery
Accepted Insurances
Awards
- America's Top Doctors
- Top Doctors:LA Area
- America's Top Doctors for Cancer
- Top Doctors:Southern California
- Super Doctor
- Fellow (FACS)
Education
-
Tulane University School of Medicine -
UCLA Medical Center
Hospital
-
Ronald Reagan UCLA Medical Center
Drug Facts
| NPI NUMBER | 1639103906 | |
| NPPES Provider LastName | BUSUTTIL | |
| NPPES Provider FirstName | RONALD | |
| NPPES Provider ZIPCode | 90095 | |
| NPPES Provider State | CA | |
| Specialty Description | General Surgery | |
| Total Claim Count | 37.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1639103906 |
| Last Name Of The Provider | BUSUTTIL |
| First Name Of The Provider | RONALD |
| View All |
Similar Doctors
|
|
Dr. Glenn T. Ault, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Siamak Barkhordarian, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kiran K. Dhanireddy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Won R. Yoon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Fady M. Kaldas, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lydia Lam, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Francesco Di Battista, MD |
|
|
Dr. Andrew S. Klein, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark P. Mueller, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shelby Resnick, MD |
|
|
Dr. Anne S. Roberts, MD |
|
|
Dr. Jeffrey S. Upperman, MD |